METHOD OF IMMUNOMODULATION USING THIONE-FORMING DISULFIDES
申请人:The GRASSETTI Family Trust
公开号:EP1383499B1
公开(公告)日:2013-03-06
COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH NLRP ACTIVITY
申请人:Novartis AG
公开号:EP3880673A1
公开(公告)日:2021-09-22
Method of immunomodulation using thione-forming disulfides
申请人:——
公开号:US20040265327A1
公开(公告)日:2004-12-30
The invention provides for the methods of modulating an immune response in an individual by administration of a thione-forming disulfide (TFD). Immunomodulatory responses include, but are not limited to, increased natural killer cell activity, expansion of NK cell population, decreased B cell population, decreased antibody production, and increased mitogenic potential. Methods of modulating such immune responses and the uses of immunomodulation are provided herein.
Inhibition of IL-1 Induced Inflammation
申请人:THIOLAB, LLC.
公开号:US20220193060A1
公开(公告)日:2022-06-23
This invention provides methods of treatment for a variety of inflammation pathologies using thione-forming disulfides (TFDs). The treatments are particularly effective in the context of inflammations primarily due to excessive activity of innate immune system components, macrophage activity and inflammation arising from excessive production of IL-1. TFD inhibition of both IL-1 and IL-6 can reduce the detrimental effects of the cytokine storms known to increase morbidity and mortality caused by certain infections, such as COVID-19 viral pneumonia.